Invesco Biotechnology & Genome ETF
PBE
#2073
ETF Rang
€0.20 Mrd.
Marktkapitalisierung
🇺🇸 US
Markt
65,54 €
Aktienkurs
-0.85%
Veränderung (1 Tag)
6.57%
Veränderung (1 Jahr)
Kategorien

Invesco Biotechnology & Genome ETF - Bestände

ETF-Bestände zum Stand 22. März 2026Anzahl der Bestände: 32

Vollständige Bestandsliste

Gewichtung %NameTickerGehaltene Aktien
6.01%
United Therapeutics CorpUTHR27237
5.50%
Illumina IncILMN104936
5.16%
Regeneron Pharmaceuticals IncREGN16699
5.09%
Alnylam Pharmaceuticals IncALNY38742
5.08%
Gilead Sciences IncGILD87349
5.05%
Biogen IncBIIB66087
4.93%
Amgen IncAMGN33685
4.88%
Incyte CorpINCY127625
3.78%
BioCryst Pharmaceuticals IncBCRX924355
3.35%
Protagonist Therapeutics IncPTGX80492
2.96%
Royalty Pharma PLCRPRX154943
2.92%
TG Therapeutics IncTGTX230561
2.89%
Neurocrine Biosciences IncNBIX53712
2.80%
PTC Therapeutics IncPTCT101976
2.79%
Catalyst Pharmaceuticals IncCPRX290795
2.71%
Exelixis IncEXEL155834
2.67%
Halozyme Therapeutics IncHALO99980
2.65%
Bio-Techne CorpTECH122122
2.64%
Veracyte IncVCYT197094
2.64%
CareDx IncCDNA365420
2.62%
Arrowhead Pharmaceuticals IncARWR110483
2.56%
BioMarin Pharmaceutical IncBMRN112335
2.51%
Repligen CorpRGEN52234
2.50%
ACADIA Pharmaceuticals IncACAD286064
2.46%
Ionis Pharmaceuticals IncIONS82319
2.44%
QIAGEN NVQGEN145040.3786
2.43%
Vericel CorpVCEL183906
2.32%
Collegium Pharmaceutical IncCOLL155728
2.23%
Theravance Biopharma IncTBPH369061
1.32%
MannKind CorpMNKD1269734
0.09%
Invesco Government & Agency PortfolioAGPXX214366.04
0.00%
CASH & EQUIVALENTSUSD5728